Policy Update: FDA Issues Draft Guidance on Artificial Intelligence in Drug and Medical Device Development

January 8, 2025
Lewis-Burke Associates, LLC

The Food and Drug Administration (FDA) issued two draft recommendations for the use of artificial intelligence (AI) in medical product development. Please see below and attached for details on these two draft recommendations. Learn more here. 

Topics

Biological Sciences topic page, Computing, Data Science & AI/ML topic page, Federal Intel/Update topic page